These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37429730)

  • 1. Dissecting Parameters Contributing to the Underprediction of Aldehyde Oxidase-Mediated Metabolic Clearance of Drugs.
    Subash S; Singh DK; Ahire DS; Khojasteh SC; Murray BP; Zientek MA; Jones RS; Kulkarni P; Smith BJ; Heyward S; Cronin CN; Prasad B
    Drug Metab Dispos; 2023 Oct; 51(10):1362-1371. PubMed ID: 37429730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Laboratory-Specific Scaling Factor to Predict the In Vivo Human Clearance of Aldehyde Oxidase Substrates.
    De Sousa Mendes M; L Orton A; Humphries HE; Jones B; Gardner I; Neuhoff S; Pilla Reddy V
    Drug Metab Dispos; 2020 Nov; 48(11):1231-1238. PubMed ID: 32893186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism.
    Subash S; Singh DK; Ahire D; Khojasteh SC; Murray BP; Zientek MA; Jones RS; Kulkarni P; Zubair F; Smith BJ; Heyward S; Leeder JS; Prasad B
    Mol Pharm; 2024 Jun; 21(6):2740-2750. PubMed ID: 38717252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde oxidase activity in fresh human skin.
    Manevski N; Balavenkatraman KK; Bertschi B; Swart P; Walles M; Camenisch G; Schiller H; Kretz O; Ling B; Wettstein R; Schaefer DJ; Pognan F; Wolf A; Litherland K
    Drug Metab Dispos; 2014 Dec; 42(12):2049-57. PubMed ID: 25249692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes.
    Hutzler JM; Yang YS; Albaugh D; Fullenwider CL; Schmenk J; Fisher MB
    Drug Metab Dispos; 2012 Feb; 40(2):267-75. PubMed ID: 22031625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde oxidase mediated drug metabolism: an underpredicted obstacle in drug discovery and development.
    Gajula SNR; Nathani TN; Patil RM; Talari S; Sonti R
    Drug Metab Rev; 2022 Nov; 54(4):427-448. PubMed ID: 36369949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Opportunities for In Vitro-In Vivo Extrapolation of Aldehyde Oxidase-Mediated Clearance: Toward a Roadmap for Quantitative Translation.
    Izat N; Bolleddula J; Abbasi A; Cheruzel L; Jones RS; Moss D; Ortega-Muro F; Parmentier Y; Peterkin VC; Tian DD; Venkatakrishnan K; Zientek MA; Barber J; Houston JB; Galetin A; Scotcher D
    Drug Metab Dispos; 2023 Dec; 51(12):1591-1606. PubMed ID: 37751998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug clearance by aldehyde oxidase: can we avoid clinical failure?
    Toselli F; Golding M; Nicolaï J; Gillent E; Chanteux H
    Xenobiotica; 2022 Aug; 52(8):890-903. PubMed ID: 36170034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase.
    Zientek M; Jiang Y; Youdim K; Obach RS
    Drug Metab Dispos; 2010 Aug; 38(8):1322-7. PubMed ID: 20444863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry.
    Crouch RD; Hutzler JM; Daniels JS
    Xenobiotica; 2018 Mar; 48(3):219-231. PubMed ID: 28281401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382.
    Hutzler JM; Cerny MA; Yang YS; Asher C; Wong D; Frederick K; Gilpin K
    Drug Metab Dispos; 2014 Oct; 42(10):1751-60. PubMed ID: 25035284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: estimation of the contribution of aldehyde oxidase to metabolic clearance.
    Strelevitz TJ; Orozco CC; Obach RS
    Drug Metab Dispos; 2012 Jul; 40(7):1441-8. PubMed ID: 22522748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Extrahepatic Aldehyde Oxidase Activity to Human Clearance.
    Kozminski KD; Selimkhanov J; Heyward S; Zientek MA
    Drug Metab Dispos; 2021 Sep; 49(9):743-749. PubMed ID: 34162687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Icotinib as a Potent and Selective Inhibitor of Aldehyde Oxidase for Reaction Phenotyping in Human Hepatocytes.
    Tang LWT; DaSilva E; Lapham K; Obach RS
    Drug Metab Dispos; 2024 May; 52(6):565-573. PubMed ID: 38565303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Aldehyde Oxidase in the Metabolic Clearance of Substituted Benzothiazoles.
    Teffera Y; Liu J; Krolikowski P; Zhao Z
    Drug Metab Lett; 2021; 14(2):126-136. PubMed ID: 34818997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.
    Argikar UA; Potter PM; Hutzler JM; Marathe PH
    AAPS J; 2016 Nov; 18(6):1391-1405. PubMed ID: 27495117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
    Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
    Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro-In Vivo Comparisons.
    Wilkinson DJ; Southall RL; Li M; Wright LM; Corfield LJ; Heeley TA; Bratby B; Mannu R; Johnson SL; Shaw V; Friett HL; Blakeburn LA; Kendrick JS; Otteneder MB
    AAPS J; 2017 Jul; 19(4):1163-1174. PubMed ID: 28474310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey.
    Abbasi A; Joswig-Jones CA; Jones JP
    Drug Metab Dispos; 2020 Dec; 48(12):1364-1371. PubMed ID: 33020066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.